30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

aap Implantate Down in 2Q19 on International Softness -



  • Sales in Germany offset by expected slowdown for international distributors after a strong first quarter
  • The polyaxial LOQTEC VA foot system will launch in the U.S. market beginning in 2020
  • Submitted an application to FDA to conduct human trials of its silver coating technology
  • Earnings impacted significantly by one-time effects of early termination of former CEO and associated legal fees


Performance by Segment

ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM):

  2Q19 2Q18 $ Chg % Chg
Trauma $2.8 $3.0 -$0.2 -7.0%
  1H19 1H18 $ Chg % Chg
Trauma $6.7 $6.2 $0.5 8.5%


Sales by Geographic Region

ORTHOWORLD estimates geographic sales and growth as follows ($MM):

  2Q19 2Q18 $ Chg % Chg
US $0.7 $0.7 $0.0 -0.2%
Ex-US $2.1 $2.3 -$0.2 -9.1%
Total $2.8 $3.0 -$0.2 -7.0%


Source: aap

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.